|
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Death (1802); Hemorrhage/Bleeding (1888); Hemorrhage, Cerebral (1889); No Code Available (3191)
|
Event Date 04/01/2020 |
Event Type
Death
|
Manufacturer Narrative
|
Beyer, s.E., sanafelt, c., pinto, d.S., weinstein, j.L., aronow, h.D., weinberg, i., carroll, b.J.(2020).Utilization and outcomes of thrombolytic.Utilization and outcomes of thrombolytic, chest(157), 645-653.
|
|
Event Description
|
Reported via journal article, bleeding requiring transfusion, surgical thrombectomy, and in hospital mortality occurred.The purpose of the article is to examine practice patterns of systemic thrombolysis and catheter-directed thrombolysis (cdt) and to compare outcomes following cdt with ultrasound facilitation (cdt-ultrasound) and cdt alone.Although various forms of catheter-directed thrombolysis (cdt) exist, the best studied and only device approved by the us food and drug administration for the management of pe is the ekosonic endovascular system (ekos).Although there were clear differences between patients receiving systemic thrombolysis and cdt, there were minimal differences in baseline patient characteristics and comorbidities between cdt-ultrasound and cdt alone.In addition, associated high-risk features of acute pe, including mechanical ventilation, hypotension, shock, and vasopressor utilization, were similar.We found no differences in bleeding, in-hospital mortality, or readmissions between cdt-ultrasound and cdt alone.Notably, the rate of major bleeding was similar to that seen in the seattle ii trial.Rates of intracranial hemorrhage were low, and they occurred in 0.6% of patients receiving cdt ultrasound.No further information is known regarding the patient events.
|
|
Search Alerts/Recalls
|
|
|